XO Life provides the brite TM platform, a unified digital hub connecting pharmaceutical and medical device manufacturers with patients and experts. This platform delivers continuous digital product and therapy support, aiming to improve patient adherence and treatment outcomes. Manufacturers gain access to standardized patient-reported outcomes and streamlined pharmacovigilance within a single application.
Funding
$14.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
GEFounders
Product
Problem
Patients often lack reliable information and continuous support regarding their treatments, leading them to seek guidance from unverified online sources and potentially impacting treatment adherence and outcomes. They also desire comparison with other patients without false statements.
Solution
XO Life's ImpactMonitor™ platform connects patients with pharmaceutical companies and healthcare experts, providing a centralized digital resource for comprehensive treatment support. The platform serves as a one-stop shop, integrating pharmaceutical and medical product manufacturers with their patients, and incorporating expert insights to deliver first-class digital treatment support. By offering manufacturer-owned product and therapy areas, along with health-relevant content, the platform aims to improve patient knowledge, loyalty, and adherence, ultimately leading to better treatment results. The platform also facilitates the collection, processing, and tracking of patient reports on product side effects, digitizing pharmacovigilance efforts.
Target Audience
The primary target audience includes pharmaceutical companies, medical device manufacturers, healthcare experts, and patients seeking reliable treatment information and support.
Features
- Centralized platform connecting patients with pharmaceutical companies and healthcare experts.
- Manufacturer-owned product and therapy areas for specific treatment guidance.
- Access to real-world patient insights through standardized and specific patient-reported outcomes.
- Digitalization of pharmacovigilance, enabling automated and user-friendly adverse event reporting.
- Expert-authored educational content on diseases and treatments.
- Digital product and treatment companions for a comprehensive portfolio.
- Integration of digital support for various therapies, such as malaria prophylaxis, treatment for Wilson's disease, and weight reduction programs.